
<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Drug Discovery Pipeline Knowledge Base</title>
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
  <header>
    <h1>Drug Discovery Pipeline Knowledge Base</h1>
    <p>Comprehensive guide to the stages of drug development</p>
  </header>
  <nav>
    <ul>
      <li><a href="target_identification.html">Target Identification</a></li>
      <li><a href="hit_discovery.html">Hit Discovery</a></li>
      <li><a href="lead_optimization.html">Lead Optimization</a></li>
      <li><a href="preclinical.html">Preclinical Development</a></li>
      <li><a href="clinical.html">Clinical Trials</a></li>
      <li><a href="regulatory.html">Regulatory Approval</a></li>
      <li><a href="post_marketing.html">Post-Marketing Surveillance</a></li>
    </ul>
  </nav>

  <main>
    <section>
      <h2>Advanced Overview of Biological Targets</h2>

  <div class="section">
    <h2>1. Proteins</h2>
    <p>Proteins are the most common drug targets due to their functional diversity.</p>
    <ul>
      <li><strong>Allosteric Sites:</strong> Enable selective modulation beyond active sites.</li>
      <li><strong>Conformational Dynamics:</strong> Ligand binding stabilizes specific conformers.</li>
      <li><strong>Post-translational Modifications:</strong> Influence druggability and function.</li>
      <li><strong>Advanced Strategies:</strong> PROTACs, molecular glues, and fragment-based discovery.</li>
    </ul>
  </div>

  <div class="section">
    <h2>2. Genes</h2>
    <p>Genes encode proteins and regulate cellular behavior. Targeting genes allows for long-term correction.</p>
    <ul>
      <li><strong>Base Editing:</strong> Precise single-nucleotide changes.</li>
      <li><strong>Prime Editing:</strong> Versatile edits without double-strand breaks.</li>
      <li><strong>Epigenetic Modulation:</strong> Reversible control via histone/DNA modifiers.</li>
      <li><strong>CRISPR-dCas9:</strong> Transcriptional regulation using epigenetic fusions.</li>
    </ul>
  </div>

  <div class="section">
    <h2>3. RNA Molecules</h2>
    <p>RNA is a versatile target for modulating protein expression and regulatory functions.</p>
    <ul>
      <li><strong>Structural Targeting:</strong> Small molecules bind RNA motifs (e.g., hairpins).</li>
      <li><strong>Splice-switching Oligos:</strong> Redirect splicing to restore function.</li>
      <li><strong>Circular RNAs:</strong> Emerging stable regulators and therapeutic agents.</li>
    </ul>
  </div>

  <div class="section">
    <h2>4. Signaling Pathways</h2>
    <p>Pathways control cell fate and are modulated at multiple levels.</p>
    <table>
      <thead>
        <tr>
          <th>Pathway</th>
          <th>Role</th>
          <th>Disease Association</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>MAPK/ERK</td>
          <td>Cell growth & survival</td>
          <td>Cancer</td>
        </tr>
        <tr>
          <td>PI3K/AKT</td>
          <td>Metabolism & apoptosis</td>
          <td>Diabetes, cancer</td>
        </tr>
        <tr>
          <td>Wnt/β-catenin</td>
          <td>Development & differentiation</td>
          <td>Colorectal cancer</td>
        </tr>
        <tr>
          <td>NF-κB</td>
          <td>Inflammation & immunity</td>
          <td>Autoimmune diseases</td>
        </tr>
      </tbody>
    </table>
    <ul>
      <li><strong>Systems Biology:</strong> Models predict compensatory mechanisms and feedback loops.</li>
      <li><strong>Multi-Omics:</strong> Phosphoproteomics and single-cell transcriptomics refine targeting.</li>
    </ul>
  </div>

  <div class="section">
    <h2>Target Validation Pipeline</h2>
    <table>
      <thead>
        <tr>
          <th>Stage</th>
          <th>Techniques</th>
          <th>Insights</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td>Target Identification</td>
          <td>GWAS, transcriptomics, proteomics</td>
          <td>Disease association, expression profiles</td>
        </tr>
        <tr>
          <td>Target Validation</td>
          <td>RNAi, CRISPR screens, chemical probes</td>
          <td>Functional relevance, druggability</td>
        </tr>
        <tr>
          <td>Structural Characterization</td>
          <td>X-ray, cryo-EM, NMR</td>
          <td>Binding site mapping, conformational states</td>
        </tr>
        <tr>
          <td>Computational Modeling</td>
          <td>Molecular dynamics, AI-based docking</td>
          <td>Predict ligand interactions, off-target effects</td>
        </tr>
      </tbody>
    </table>
  </div>

  <div class="section">
    <h2>AI in Target Discovery</h2>
    <ul>
      <li><strong>Deep Learning:</strong> Predicts protein–ligand interactions and novel pockets.</li>
      <li><strong>Graph Neural Networks:</strong> Model signaling pathways as dynamic networks.</li>
      <li><strong>Multi-modal Integration:</strong> Combines omics and imaging for prioritization.</li>
    </ul>
  </div>

</section>
  </main>
  <footer>
    <p>&copy; 2025 Drug Discovery Knowledge Base</p>
  </footer>
</body>
</html>
